XGN
Price:
$3.14
Market Cap:
$54.59M
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-09-19
Stock Exchange
NASDAQ
Ticker
XGN
According to Exagen Inc.’s latest financial reports and current stock price. The company's current ROE is -78.90%. This represents a change of 305.05% compared to the average of -19.48% of the last 4 quarters.
The mean historical ROE of Exagen Inc. over the last ten years is -243.69%. The current -78.90% ROE has changed -67.62% with respect to the historical average. Over the past ten years (40 quarters), XGN's ROE was at its highest in in the March 2019 quarter at 670.97%. The ROE was at its lowest in in the December 2013 quarter at -1431.71%.
Average
-243.69%
Median
-26.62%
Minimum
-2992.46%
Maximum
552.63%
Discovering the peaks and valleys of Exagen Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.87%
Maximum Annual ROE = 552.63%
Minimum Annual Increase = -118.18%
Minimum Annual ROE = -2992.46%
Year | ROE | Change |
---|---|---|
2023 | -104.38% | -6.47% |
2022 | -111.60% | 253.03% |
2021 | -31.61% | -20.74% |
2020 | -39.88% | 84.41% |
2019 | -21.63% | -118.18% |
2018 | 118.98% | -78.47% |
2017 | 552.63% | 539.08% |
2015 | 86.47% | -18.87% |
2014 | 106.58% | -103.56% |
2013 | -2992.46% | 1.87% |
The current ROE of Exagen Inc. (XGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-82.53%
5-year avg
-61.82%
10-year avg
-243.69%
Exagen Inc.’s ROE is less than FONAR Corporation (9.60%), greater than Burning Rock Biotech Limited (-74.92%), greater than Sera Prognostics, Inc. (-46.71%), greater than Olink Holding AB (publ) (-7.07%), less than LumiraDx Limited (122.57%), greater than Genetron Holdings Limited (-36.51%), less than Castle Biosciences, Inc. (-0.77%), less than Sotera Health Company (9.59%), greater than Psychemedics Corporation (-69.81%), greater than DarioHealth Corp. (-7.91%), greater than Biodesix, Inc. (-525.32%),
Company | ROE | Market cap |
---|---|---|
9.60% | $104.35M | |
-74.92% | $48.03M | |
-46.71% | $234.91M | |
-7.07% | $3.24B | |
122.57% | $0 | |
-36.51% | $127.29M | |
-0.77% | $813.24M | |
9.59% | $4.43B | |
-69.81% | $13.28M | |
-7.91% | $25.07M | |
-525.32% | $268.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Exagen Inc.'s ROE?
How is the ROE calculated for Exagen Inc. (XGN)?
What is the highest ROE for Exagen Inc. (XGN)?
What is the 3-year average ROE for Exagen Inc. (XGN)?
What is the 5-year average ROE for Exagen Inc. (XGN)?
How does the current ROE for Exagen Inc. (XGN) compare to its historical average?